Astragalus polysaccharide alleviates H(2)O(2)-triggered oxidative injury in human umbilical vein endothelial cells via promoting KLF2.

Li D, Liu Y, Xu R, Jia X, Li X, Huo C, Wang X

Open source

DOI
10.1080/21691401.2019.1621886
Published
2019 Dec
Container
Artificial cells, nanomedicine, and biotechnology
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/21691401.2019.1621886,
  title = {Astragalus polysaccharide alleviates H(2)O(2)-triggered oxidative injury in human umbilical vein endothelial cells via promoting KLF2.},
  author = {Li D and Liu Y and Xu R and Jia X and Li X and Huo C and Wang X},
  year = {2019},
  journal = {Artificial cells, nanomedicine, and biotechnology},
  doi = {10.1080/21691401.2019.1621886},
  url = {https://doi.org/10.1080/21691401.2019.1621886}
}

RIS

TY  - JOUR
TI  - Astragalus polysaccharide alleviates H(2)O(2)-triggered oxidative injury in human umbilical vein endothelial cells via promoting KLF2.
AU  - Li D
AU  - Liu Y
AU  - Xu R
AU  - Jia X
AU  - Li X
AU  - Huo C
AU  - Wang X
PY  - 2019
JO  - Artificial cells, nanomedicine, and biotechnology
DO  - 10.1080/21691401.2019.1621886
UR  - https://doi.org/10.1080/21691401.2019.1621886
ER  - 

APA

D, L., Y, L., R, X., X, J., X, L., C, H., & X, W. (2019). Astragalus polysaccharide alleviates H(2)O(2)-triggered oxidative injury in human umbilical vein endothelial cells via promoting KLF2.. Artificial cells, nanomedicine, and biotechnology. https://doi.org/10.1080/21691401.2019.1621886

Source records